Statement from the REMAP-CAP trial

Anticoagulant REMAP-CAP

Statement from the REMAP-CAP trial: International Trials of Blood Thinners Pause Enrolment of Critically Ill COVID-19 Patients Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrolment for one group of patients. Among critically ill COVID-19 patients requiring intensive care unit (ICU) support, […]

Read More… from Statement from the REMAP-CAP trial

Migrants and refugees say COVID-19 has dramatically worsened their lives

migrants and refugees

Migrants and refugees say COVID-19 has dramatically worsened their lives: The COVID-19 pandemic has had a highly negative impact on the living and working conditions of refugees and migrants reveals a new WHO study, launched on International Migrants Day. More than 30,000 refugees and migrants from different regions around the world participated in the first ever […]

Read More… from Migrants and refugees say COVID-19 has dramatically worsened their lives

Reducing coronavirus spread during dental procedures

dental procedures

Coronavirus spread during dental procedures could be reduced with slower drill rotation: Researchers from Imperial College London and King’s College London have found that careful selection and operation of dental drills can minimise the spread of COVID-19 through aerosols. Dental procedures can pose a high risk of viral transmission because the tools that are used often […]

Read More… from Reducing coronavirus spread during dental procedures

Lecture from Government Chief Scientific Adviser, Sir Patrick Vallance

Science in Government

Sir Patrick Vallance delivers Hammersmith and White City Distinguished Lecture: Government Chief Scientific Adviser, Sir Patrick Vallance, spoke on science in government and shared insights into the UK’s response to COVID-19. Sir Patrick Vallance delivered this year’s Hammersmith and White City Distinguished Christmas Lecture in an online event for College staff and students. Formerly President […]

Read More… from Lecture from Government Chief Scientific Adviser, Sir Patrick Vallance

Lasting Power of Attorney and the Covid vaccine

refuse the Covid vaccine

Do I have the right to refuse the Covid vaccine on behalf of a relative? The requirement for an Lasting Power of Attorney (LPA) to navigate the welfare of a venerable loved one is discussed here by Chris Partington, Partner and Head of Private Client at Slater Heelis: Over the coming weeks, the first 800,000 […]

Read More… from Lasting Power of Attorney and the Covid vaccine

Update on The University of Queensland COVID-19 vaccine

strong support

Friday, 11th December, 2020: The University of Queensland (UQ) and CSL today announce that the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a strong safety profile. There were no serious adverse events or safety concerns reported in the 216 trial participants. However, […]

Read More… from Update on The University of Queensland COVID-19 vaccine

Less than 50% willing to get a COVID-19 vaccine

willing to get a COVID-19 vaccine

Less than half of people currently willing to get a COVID-19 vaccine, international survey suggests: A new report on the public’s attitudes towards coronavirus vaccines has revealed that around half of those surveyed (51%) may be willing to get vaccinated next year.  Findings from a survey of 13,500 people across 15 countries* in November suggest that […]

Read More… from Less than 50% willing to get a COVID-19 vaccine

People with rare autoimmune diseases at increased risk of dying during Covid-19

autoimmune

A new study, led by experts from the University of Nottingham, has shown that people with rare autoimmune rheumatic diseases are at a greater risk of dying at a younger age during the Covid-19 pandemic. The findings of the study, published in the British Society for Rheumatology’s journal, Rheumatology, was the work of a team […]

Read More… from People with rare autoimmune diseases at increased risk of dying during Covid-19

Lung disease diagnosis wait times

Lung disease diagnosis wait times: 1 in 3 people with lung disease end up waiting longer than six months for a diagnosis. New research released today coincides with a warning from Taskforce for Lung Health that the redistribution of respiratory funding to COVID-19 patients could have a serious impact on future care. According to a […]

Read More… from Lung disease diagnosis wait times

COVID-19: cancer diagnosis and care

Cancer care and diagnosis

COVID-19: cancer diagnosis and care: Covid-19 may have changed the way people have been diagnosed with cancer and how they receive care – new study to investigate by Natasha Meredith of the University of Surrey An important new study from the University of Surrey and UCL is set to investigate how rapid changes in cancer […]

Read More… from COVID-19: cancer diagnosis and care